Fresh Recalls

FDAClass III · Drug · Recall D-0552-2026 · Recalled June 10, 2026

Lidocaine HCl Injection recall — Eugia US LLC

Agency report date: June 10, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Lidocaine HCl Injection
Company / brand
Eugia US
Lot / serial / date codes
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Distribution
US Nationwide.
Agency product description and boundaries

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: Lidocaine HCl Injection recall status

3. Open the official notice or contact

Official recall ID
D-0552-2026
Brand
All Eugia US recalls
Classification
Class III
Units affected
168,300 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
East Windsor, NJ, United States
Firm address
279 Princeton Hightstown Rd, 08520-1401

Identifying details (verbatim from the notice)

Product codes / lots
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Distribution
US Nationwide.
Firm notified the public via
Letter
FDA event ID
99024
Recall initiated
May 18, 2026
FDA classified
May 29, 2026
FDA report date
June 10, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved September 8, 2026 at 6:00 PM UTC.

Report a data error on this page